All In Biotech

Drug Trial Radar · NCT03594422

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of Oral HQP1351 in Patients With GIST or Other Solid Tumors.

Last checked: Nov 20, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jul 11, 2018

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Ascentage Pharma Group Inc.Industry
Sponsor type
Industry
Collaborators
HealthQuest Pharma Inc.
First posted
Jul 20, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Multi-center, Open-label Phase 1 Study to Determine the Recommend Phase 2 Dose (RP2D) and Evaluate PK/PD and preliminary Efficacy of HQP1351 in Patients With GIST or Other Solid Tumors.

Conditions

  • Gastrointestinal Stromal Tumor (GIST)
  • Solid Tumor, Adult

Interventions

  • HQP1351Drug

    HQP1351 Orally, once every other day (QOD) for consecutive 4 weeks each cycle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and toleranceTime frame: 30 days after the last dose of HQP1351

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Chinese PLA general hospital, Beijing, China

    Beijing, China · Recruiting

  • Fudan University Shanghai Cancer Center

    Shanghai, China · Recruiting

  • Sun-Yat Sen University Cancer Center

    Guangzhou, Guangdong, China · Recruiting

  • Guangdong general hospital

    Guangzhou, Guangdong, China · Recruiting

  • Henan cancer hospital

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital Tongji Medical College of Huazhong University of Science ang Technology

    Wuhan, Hubei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.